Table of Contents

<< Previous Issue

Aug 2026 (Vol: 2026, Issue: 8)

Section: Licensing
Innovent Signs US$1.1B Licensing Alliance with Spero for IBI355 (SP001), for the Teatment Immune-Mediated Diseases Published: 5 Aug-2026
By: Naini Anand
Abstract Fulltext:
Section: Mergers & Acquisitions
Novartis Expands Oncology Portfolio with US$1.5 B Acquisition of Myricx Published: 1 Aug-2026
By: Sanya Sekhri
Abstract Fulltext:
Argenx to Acquire Forte Biosciences for US$2.2 B Published: 1 Aug-2026
By: Ayush Saxena
Abstract Fulltext:
Section: Research & Development
Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases Published: 7 Aug-2026
By: Nikita Negi
Abstract Fulltext:
Johnson & Johnson Pays Sail Biomedicines US$785M Upfront to Develop In Vivo CAR-T Therapies for Autoimmune Disease Published: 8 Aug-2026
By: Sanya Sekhri
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents